Barclays reaffirmed their overweight rating on shares of Microsoft (NASDAQ:MSFT) in a research report sent to investors on Friday morning. Barclays currently has a $117.00 target price on the software giant’s stock, up from their previous target price of $108.00.
Source: ThinkstockUntil about 2008 or so, discussion about the future price of crude oil was directed by the concept of peak oil. That is, when does the world reach peak production, after which the price of crude will skyrocket. In less than a decade, the discussion is now focused on the concept of “peak demand,” the point at which global demand for crude begins to decline.
Theres reason tothink that President Trump might target uranium imports for tariffs after imposing them on solar equipment back in January and then another announcing another round late last week on steel and aluminum (China has alreadyresponded by announcing planned tariffs on imports of U.S. pork, recycled aluminum, steel pipes, fruit and wine). At first glance, you might think that wouldcause....More>>>
AVX Corp (NYSE:AVX) files its latest 10-K with SEC for the fiscal year ended on March 31, 2017. AVX Corp is a manufacturer and supplier of passive electronic components interconnect devices, and related products. Its electronic component products are ceramic and tantalum capacitors, film capacitors, varistors, filters and other components. AVX Corp has a market cap of $2.74 billion; its shares were....More>>>
Thanks to our highly bureaucratic FDA, the cost of bringing a new drug to market today is at least $2.5 billion — and often much more. Fewer than one in 10 medicines that start human clinical trials succeed, notes Mark Skousen, editor of High-Income Alert.
Pharmaceutical companies eat those costs year in and year out. Only one of every 10,000 compounds that enters the pipeline....More>>>
Medical devices can change lives, and NuVasive (NASDAQ:NUVA) prides itself on making spinal surgery as painless and simple as possible. The company specializes in devices to provide procedurally integrated surgical solutions that are minimally disruptive, and NuVasive products have gained popularity over time.
Coming into Tuesday’s first-quarter financial report, NuVasive investors....More>>>
Oil prices hit a 10-year low in January 2016, but since then they rose 47%. That means the top oil stocks of 2016 saw huge returns.
To give investors an overview of how well oil stocks did in 2016, Money Morning made a list of thetop oil stocks of 2016. To make our list of the top oil stocks, we looked at companies with biggest stock price growth and market cap of at least $1 billion.
Ingevity (NYSE:NGVT) had its price target increased by Loop Capital to $89.00 in a research note published on Wednesday. The brokerage currently has a $90.05 rating on the stock. The analysts noted that the move was a valuation call.
A number of other analysts have also weighed in on the
BP, (BP) gets a lot of interest from investors, and has a lot of articles written about it. Many of these articles feature the generous dividend the company pays, upon which many retirees rely for income. Other articles feature the depressed stock price relative to its cohort group,
The S&P 500 Consumer Staples Index has tanked 6% over the past month amid mixed first-quarter earnings from the group's biggest names. For some on Wall Street, Coca-Cola's (KO) report card disappointed in the area of pricing power both in the U.S. and Eur